Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2026-06-09 21:20:56 ET · period of report 2026-06-05 · accession 0001628280-26-042040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 21:20 | 2026-06-05 | ARQT | Gilbert Halley E | Dir | A - Grant | $0.00 | +5,778 | 27.9K | +26% | $0 |
| D | 2026-06-09 21:20 | 2026-06-05 | ARQT | Gilbert Halley E | Dir | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | A | A | 5,778 | $0.00 | 27,901 | D | — | — | (F1) Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2026-06-05 | A | A | 16,667 | $0.00 | 16,667 | D | $21.23 · — to 2036-06-05 | 16,667 Common Stock | (F2) The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. |